The dopamine hypothesis of schizophrenia is
a structure, accrediting indications of schizophrenia to a distressed and agitated dopaminergic indicator
transduction. The growth of enriched antipsychotic medicines was directed by a hunt
for dopamine blockers founded on the notion that schizophrenia is, partly, a
hyperdopaminergic state. So from the choices given above, it can be concluded
that, drugs that block the effects of dopamine in the brain reduce or eliminate
symptoms of schizophrenia.
